Sfoglia per Autore
Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy
2010 Campo, Gianluca Calogero; Fileti, L; de Cesare, N; Meliga, E; Furgieri, A; Russo, F; Colangelo, S; Brugaletta, S; Ferrari, Roberto; Valgimigli, M.
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention
file con accesso da definire2011 Campo, Gianluca Calogero; Ferraresi, Paolo; Marchesini, Jlenia; Bernardi, Francesco; Valgimigli, Marco
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome
file con accesso da definire2011 Campo, Gianluca Calogero; Parrinello, G.; Ferraresi, Paolo; Lunghi, Barbara; Tebaldi, Matteo; Miccoli, M.; Marchesini, Jlenia; Bernardi, Francesco; Ferrari, Roberto; Valgimigli, Marco
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial
2012 Ferrante, G; Presbitero, P; Corrada, E; Campo, Gianluca Calogero; Bolognese, L; Vassanelli, C; Colangelo, S; De Cesare, N; E., Rodriguez A; Bramucci, E; Moreno, R; Piva, T; Sheiban, I; Pasquetto, G; Prati, F; Nazzaro, Ms; Ferrari, Roberto; Valgimigli, M.
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention
file con accesso da definire2013 Biscaglia, S.; Tebaldi, M.; Vranckx, P.; Campo, G.; Valgimigli, M.
Stable angina pectoris
file con accesso da definire2014 Valgimigli, M.; Biscaglia, S.
Prospective validation of the bleeding academic research consortium classification in the all-comer PRODIGY trial
file con accesso da definire2014 Vranckx, P.; Leonardi, S.; Tebaldi, M.; Biscaglia, S.; Parrinello, G.; Rao, S. V.; Mehran, R.; Valgimigli, M.
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial
file con accesso da definire2015 Crimi, G.; Leonardi, S.; Costa, F.; Ariotti, S.; Tebaldi, M.; Biscaglia, S.; Valgimigli, M.
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT)
2016 Komajda, M; Weidinger, F; Kerneis, M; Cosentino, F; Cremonesi, A; Ferrari, Roberto; Kownator, S; Steg, Pg; Tavazzi, Luigi; Valgimigli, Marco; Szwed, H; Majda, W; Olivari, Z; Van Belle, E; Shlyakhto, Ev; Mintale, I; Slapikas, R; Rittger, H; Mendes, M; Tsioufis, C; Balanescu, S; Laroche, C; Maggioni, Aldo Pietro
Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial
2018 Schur, Nadine; Brugaletta, Salvatore; Cequier, Angel; Iñiguez, Andrés; Serra, Antonio; Jiménez-Quevedo, Pilar; Mainar, Vicente; Campo, Gianluca; Tespili, Maurizio; Heijer, Peter den; Bethencourt, Armando; Vazquez, Nicolás; Valgimigli, Marco; Serruys, Patrick W.; Ademi, Zanfina; Schwenkglenks, Matthias; Sabaté, Manel
Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates
2019 Gargiulo, Giuseppe; Patialiakas, Athanasios; Piccolo, Raffaele; Thury, Attila; Colangelo, Salvatore; Campo, Gianluca; Tebaldi, Matteo; Ungi, Imre; Tondi, Stefano; Roffi, Marco; Menozzi, Alberto; de Cesare, Nicoletta; Garbo, Roberto; Meliga, Emanuele; Testa, Luca; Gabriel, Henrique Mesquita; Ferlini, Marco; Liistro, Francesco; Dellavalle, Antonio; Vranckx, Pascal; Briguori, Carlo; Windecker, Stephan; Valgimigli, Marco
Obstructive sleep apnoea syndrome and endothelial function: potential impact of different treatment strategies—meta-analysis of prospective studies
2019 Cammaroto, G.; Costa, F.; Ruiz, M. V. G.; Ando, G.; Vicini, C.; Montevecchi, F.; Galletti, C.; Galletti, F.; Valgimigli, M.
Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention? Insights From the EXAMINATION Trial
2019 Costa, F.; Brugaletta, S.; Pernigotti, A.; Flores-Ulmanzor, E.; Ortega-Paz, L.; Cequier, A.; Iniguez, A.; Serra, A.; Jimenez-Quevedo, P.; Mainar, V.; Campo, G.; Tespili, M.; den Heijer, P.; Bethencourt, A.; Vazquez, N.; van Es, G. A.; Backx, B.; Valgimigli, M.; Serruys, P.; Sabate, M.
Pharmacogenomic Polygenic Response Score Predicts Ischemic Events and Cardiovascular Mortality in Clopidogrel-Treated Patients
2020 Lewis, Joshua P; Backman, Joshua D; Reny, Jean-Luc; Bergmeijer, Thomas O; Mitchell, Braxton D; Ritchie, Marylyn D; Déry, Jean-Pierre; Pakyz, Ruth E; Gong, Li; Ryan, Kathleen; Kim, Eun-Young; Aradi, Daniel; Fernandez-Cadenas, Israel; Lee, Ming Ta Michael; Whaley, Ryan M; Montaner, Joan; Gensini, Gian Franco; Cleator, John H; Chang, Kiyuk; Holmvang, Lene; Hochholzer, Willibald; Roden, Dan M; Winter, Stefan; Altman, Russ; Alexopoulos, Dimitrios; Kim, Ho-Sook; Gawaz, Meinrad; Bliden, Kevin; Valgimigli, Marco; Marcucci, Rossella; Campo, Gianluca; Schaeffeler, Elke; Dridi, Nadia P; Wen, Ming-Shien; Shin, Jae Gook; Fontana, Pierre; Giusti, Betti; Geisler, Tobias; Kubo, Michiaki; Trenk, Dietmar; Siller-Matula, Jolanta M; Ten Berg, Jurriën M; Gurbel, Paul A; Schwab, Matthias; Klein, Teri E; Shuldiner, Alan R
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI
2021 Valgimigli, M.; Cao, D.; Angiolillo, D. J.; Bangalore, S.; Bhatt, D. L.; Ge, J.; Hermiller, J.; Makkar, R. R.; Neumann, F. -J.; Saito, S.; Picon, H.; Toelg, R.; Maksoud, A.; Chehab, B. M.; Choi, J. W.; Campo, G.; De la Torre Hernandez, J. M.; Kunadian, V.; Sardella, G.; Thiele, H.; Varenne, O.; Vranckx, P.; Windecker, S.; Zhou, Y.; Krucoff, M. W.; Ruster, K.; Zheng, Y.; Mehran, R.
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale: The FABOLUS FASTER Trial
2021 Gargiulo, G.; Esposito, G.; Cirillo, P.; Nagler, M.; Minuz, P.; Campo, G.; Gragnano, F.; Manavifar, N.; Piccolo, R.; Avvedimento, M.; Tebaldi, M.; Wahl, A.; Hunziker, L.; Billinger, M.; Heg, D.; Windecker, S.; Valgimigli, M.
Cohort profile The ESC-EORP Chronic Ischemic Cardiovascular Disease Long-Term (CICD LT) registry
2021 Komajda, Michel; Cosentino, Francesco; Ferrari, Roberto; Laroche, Cécile; Maggioni, Aldo; Steg, Philippe Gabriel; Tavazzi, Luigi; Kerneis, Mathieu; Valgimigli, Marco; Gale, Chris P
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial
2021 Landi, Antonio; Branca, Mattia; Andò, Giuseppe; Russo, Filippo; Frigoli, Enrico; Gargiulo, Giuseppe; Briguori, Carlo; Vranckx, Pascal; Leonardi, Sergio; Gragnano, Felice; Calabrò, Paolo; Campo, Gianluca; Ambrosio, Giuseppe; Santucci, Andrea; Varbella, Ferdinando; Zaro, Tiziana; Heg, Dik; Windecker, Stephan; Jüni, Peter; Pedrazzini, Giovanni; Valgimigli, Marco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy | 2010 | Campo, Gianluca Calogero; Fileti, L; de Cesare, N; Meliga, E; Furgieri, A; Russo, F; Colangelo, S...; Brugaletta, S; Ferrari, Roberto; Valgimigli, M. | |
| Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention | 2011 | Campo, Gianluca Calogero; Ferraresi, Paolo; Marchesini, Jlenia; Bernardi, Francesco; Valgimigli, ...Marco | file con accesso da definire |
| Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome | 2011 | Campo, Gianluca Calogero; Parrinello, G.; Ferraresi, Paolo; Lunghi, Barbara; Tebaldi, Matteo; Mic...coli, M.; Marchesini, Jlenia; Bernardi, Francesco; Ferrari, Roberto; Valgimigli, Marco | file con accesso da definire |
| Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial | 2012 | Ferrante, G; Presbitero, P; Corrada, E; Campo, Gianluca Calogero; Bolognese, L; Vassanelli, C; Co...langelo, S; De Cesare, N; E., Rodriguez A; Bramucci, E; Moreno, R; Piva, T; Sheiban, I; Pasquetto, G; Prati, F; Nazzaro, Ms; Ferrari, Roberto; Valgimigli, M. | |
| Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention | 2013 | Biscaglia, S.; Tebaldi, M.; Vranckx, P.; Campo, G.; Valgimigli, M. | file con accesso da definire |
| Stable angina pectoris | 2014 | Valgimigli, M.; Biscaglia, S. | file con accesso da definire |
| Prospective validation of the bleeding academic research consortium classification in the all-comer PRODIGY trial | 2014 | Vranckx, P.; Leonardi, S.; Tebaldi, M.; Biscaglia, S.; Parrinello, G.; Rao, S. V.; Mehran, R.; Va...lgimigli, M. | file con accesso da definire |
| Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial | 2015 | Crimi, G.; Leonardi, S.; Costa, F.; Ariotti, S.; Tebaldi, M.; Biscaglia, S.; Valgimigli, M. | file con accesso da definire |
| EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT) | 2016 | Komajda, M; Weidinger, F; Kerneis, M; Cosentino, F; Cremonesi, A; Ferrari, Roberto; Kownator, S; ...Steg, Pg; Tavazzi, Luigi; Valgimigli, Marco; Szwed, H; Majda, W; Olivari, Z; Van Belle, E; Shlyakhto, Ev; Mintale, I; Slapikas, R; Rittger, H; Mendes, M; Tsioufis, C; Balanescu, S; Laroche, C; Maggioni, Aldo Pietro | |
| Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial | 2018 | Schur, Nadine; Brugaletta, Salvatore; Cequier, Angel; Iñiguez, Andrés; Serra, Antonio; Jiménez-Qu...evedo, Pilar; Mainar, Vicente; Campo, Gianluca; Tespili, Maurizio; Heijer, Peter den; Bethencourt, Armando; Vazquez, Nicolás; Valgimigli, Marco; Serruys, Patrick W.; Ademi, Zanfina; Schwenkglenks, Matthias; Sabaté, Manel | |
| Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates | 2019 | Gargiulo, Giuseppe; Patialiakas, Athanasios; Piccolo, Raffaele; Thury, Attila; Colangelo, Salvato...re; Campo, Gianluca; Tebaldi, Matteo; Ungi, Imre; Tondi, Stefano; Roffi, Marco; Menozzi, Alberto; de Cesare, Nicoletta; Garbo, Roberto; Meliga, Emanuele; Testa, Luca; Gabriel, Henrique Mesquita; Ferlini, Marco; Liistro, Francesco; Dellavalle, Antonio; Vranckx, Pascal; Briguori, Carlo; Windecker, Stephan; Valgimigli, Marco | |
| Obstructive sleep apnoea syndrome and endothelial function: potential impact of different treatment strategies—meta-analysis of prospective studies | 2019 | Cammaroto, G.; Costa, F.; Ruiz, M. V. G.; Ando, G.; Vicini, C.; Montevecchi, F.; Galletti, C.; Ga...lletti, F.; Valgimigli, M. | |
| Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention? Insights From the EXAMINATION Trial | 2019 | Costa, F.; Brugaletta, S.; Pernigotti, A.; Flores-Ulmanzor, E.; Ortega-Paz, L.; Cequier, A.; Inig...uez, A.; Serra, A.; Jimenez-Quevedo, P.; Mainar, V.; Campo, G.; Tespili, M.; den Heijer, P.; Bethencourt, A.; Vazquez, N.; van Es, G. A.; Backx, B.; Valgimigli, M.; Serruys, P.; Sabate, M. | |
| Pharmacogenomic Polygenic Response Score Predicts Ischemic Events and Cardiovascular Mortality in Clopidogrel-Treated Patients | 2020 | Lewis, Joshua P; Backman, Joshua D; Reny, Jean-Luc; Bergmeijer, Thomas O; Mitchell, Braxton D; Ri...tchie, Marylyn D; Déry, Jean-Pierre; Pakyz, Ruth E; Gong, Li; Ryan, Kathleen; Kim, Eun-Young; Aradi, Daniel; Fernandez-Cadenas, Israel; Lee, Ming Ta Michael; Whaley, Ryan M; Montaner, Joan; Gensini, Gian Franco; Cleator, John H; Chang, Kiyuk; Holmvang, Lene; Hochholzer, Willibald; Roden, Dan M; Winter, Stefan; Altman, Russ; Alexopoulos, Dimitrios; Kim, Ho-Sook; Gawaz, Meinrad; Bliden, Kevin; Valgimigli, Marco; Marcucci, Rossella; Campo, Gianluca; Schaeffeler, Elke; Dridi, Nadia P; Wen, Ming-Shien; Shin, Jae Gook; Fontana, Pierre; Giusti, Betti; Geisler, Tobias; Kubo, Michiaki; Trenk, Dietmar; Siller-Matula, Jolanta M; Ten Berg, Jurriën M; Gurbel, Paul A; Schwab, Matthias; Klein, Teri E; Shuldiner, Alan R | |
| Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI | 2021 | Valgimigli, M.; Cao, D.; Angiolillo, D. J.; Bangalore, S.; Bhatt, D. L.; Ge, J.; Hermiller, J.; M...akkar, R. R.; Neumann, F. -J.; Saito, S.; Picon, H.; Toelg, R.; Maksoud, A.; Chehab, B. M.; Choi, J. W.; Campo, G.; De la Torre Hernandez, J. M.; Kunadian, V.; Sardella, G.; Thiele, H.; Varenne, O.; Vranckx, P.; Windecker, S.; Zhou, Y.; Krucoff, M. W.; Ruster, K.; Zheng, Y.; Mehran, R. | |
| Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale: The FABOLUS FASTER Trial | 2021 | Gargiulo, G.; Esposito, G.; Cirillo, P.; Nagler, M.; Minuz, P.; Campo, G.; Gragnano, F.; Manavifa...r, N.; Piccolo, R.; Avvedimento, M.; Tebaldi, M.; Wahl, A.; Hunziker, L.; Billinger, M.; Heg, D.; Windecker, S.; Valgimigli, M. | |
| Cohort profile The ESC-EORP Chronic Ischemic Cardiovascular Disease Long-Term (CICD LT) registry | 2021 | Komajda, Michel; Cosentino, Francesco; Ferrari, Roberto; Laroche, Cécile; Maggioni, Aldo; Steg, P...hilippe Gabriel; Tavazzi, Luigi; Kerneis, Mathieu; Valgimigli, Marco; Gale, Chris P | |
| Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial | 2021 | Landi, Antonio; Branca, Mattia; Andò, Giuseppe; Russo, Filippo; Frigoli, Enrico; Gargiulo, Giusep...pe; Briguori, Carlo; Vranckx, Pascal; Leonardi, Sergio; Gragnano, Felice; Calabrò, Paolo; Campo, Gianluca; Ambrosio, Giuseppe; Santucci, Andrea; Varbella, Ferdinando; Zaro, Tiziana; Heg, Dik; Windecker, Stephan; Jüni, Peter; Pedrazzini, Giovanni; Valgimigli, Marco |
Legenda icone
- file ad accesso aperto
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile